Companion Diagnostics
Clinicians have always practiced personalized medicine. Recent advances in targeted therapies and diagnostics facilitate the practice of precision medicine, identifying which patients are most likely to respond favorably to particular therapies. As the leading provider of specialized diagnostic testing, LabCorp is the clinical laboratory for personalized medicine. LabCorp has a focused companion diagnostics department, facilitating the translation of putative biomarkers from clinical trials into clinical diagnostic tests.
LabCorp’s scientific leadership in esoteric testing augments its regulatory and commercial expertise in diagnostic testing – with focused resources utilizing our scientific leadership and expertise in laboratory testing, project team members who are highly experienced in FDA filings and approvals, and a test commercialization network.
Our companion diagnostics vision is based on our core strengths of identifying, developing, and commercializing diagnostic technologies – as well as having the ability to support global clinical trials. We have formed collaborations with several medical device and pharmaceutical sponsors to ensure the timely development, regulatory approval and distribution of companion diagnostics so that broad testing access enables therapeutic adoption.